Bempikibart demonstrated positive, durable responses among patients with severe to very severe alopecia areata, according to ...
18h
Zacks Investment Research on MSNLLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia StudyEli Lilly LLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients ...
Oral ivarmacitinib, administered 4 mg or 8 mg once daily, significantly induced hair regrowth at 24 weeks vs. placebo in ...
Hair transplant prices could be set to soar after the taxman won a legal battle against a clinic that argued the procedure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results